NATERA, INC. Payments to Acquire Available-for-sale Securities
NATERA, INC. (NTRA) reported Payments to Acquire Available-for-sale Securities of $197.01 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2019-11-08
- NATERA, INC. payments to acquire available-for-sale securities for the quarter ending 2019-09-30 was $34.83M, a 63.13% decline year-over-year.
- NATERA, INC. payments to acquire available-for-sale securities for the quarter ending 2019-06-30 was $143.55M, a 1254.35% increase year-over-year.
- NATERA, INC. payments to acquire available-for-sale securities for the quarter ending 2019-03-31 was $18.63M, a 86.56% increase year-over-year.
- NATERA, INC. payments to acquire available-for-sale securities for the quarter ending 2018-12-31 was $55.20M, a 37.66% decline year-over-year.
- NATERA, INC. payments to acquire available-for-sale securities for fiscal 2018 was $170.27M, a 37.59% decline from fiscal 2017.
- NATERA, INC. payments to acquire available-for-sale securities for fiscal 2017 was $272.82M, a 409.73% increase from fiscal 2016.
- NATERA, INC. payments to acquire available-for-sale securities for fiscal 2016 was $53.52M, a 73.67% decline from fiscal 2015.
- NATERA, INC. payments to acquire available-for-sale securities for fiscal 2015 was $203.29M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 3 month as first filed | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | $34.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $178.38M derived: sum of 2 quarters · filed 2019-11-08 | $197.01M 10-Q · filed 2019-11-08 | $252.21M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2019-06-30 | $143.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $162.18M 10-Q · filed 2019-08-09 | $217.38M derived: sum of 3 quarters · filed 2019-08-09 | $311.86M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2019-03-31 | $18.63M 10-Q · filed 2019-05-10 | $73.83M derived: sum of 2 quarters · filed 2019-05-10 | $168.31M derived: sum of 3 quarters · filed 2019-11-08 | $178.91M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-12-31 | $55.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $149.68M derived: sum of 2 quarters · filed 2019-11-08 | $160.28M derived: sum of 3 quarters · filed 2019-11-08 | $170.27M 10-K · filed 2019-03-15 | |
| 2018-09-30 | $94.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $105.08M derived: sum of 2 quarters · filed 2019-11-08 | $115.07M 10-Q · filed 2019-11-08 | $203.62M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | $10.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $20.58M 10-Q · filed 2019-08-09 | $109.14M derived: sum of 3 quarters · filed 2019-08-09 | $289.18M derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | $9.98M 10-Q · filed 2019-05-10 | $9.99M 10-Q · filed 2018-05-10 | $98.54M derived: sum of 2 quarters · filed 2019-05-10 | $278.58M derived: sum of 3 quarters · filed 2019-05-10 | $278.81M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $88.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $268.60M derived: sum of 2 quarters · filed 2019-03-15 | $268.82M derived: sum of 3 quarters · filed 2019-03-15 | $272.82M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $180.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $180.27M derived: sum of 2 quarters · filed 2018-11-09 | $184.26M 10-Q · filed 2018-11-09 | $189.27M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.22M 10-Q · filed 2018-08-09 | $9.22M derived: sum of 3 quarters · filed 2019-03-15 | $27.62M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-03-31 | $4.00M 10-Q · filed 2018-05-10 | $9.00M derived: sum of 2 quarters · filed 2019-03-15 | $27.40M derived: sum of 3 quarters · filed 2019-03-15 | $43.44M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2016-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $23.40M derived: sum of 2 quarters · filed 2019-03-15 | $39.44M derived: sum of 3 quarters · filed 2019-03-15 | $53.52M 10-K · filed 2019-03-15 | |
| 2016-09-30 | $18.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $34.44M derived: sum of 2 quarters · filed 2017-11-09 | $48.52M 10-Q · filed 2017-11-09 | $225.46M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-06-30 | $16.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $30.12M 10-Q · filed 2017-08-09 | $207.06M derived: sum of 3 quarters · filed 2018-03-15 | ||
| 2016-03-31 | $14.08M 10-Q · filed 2017-05-10 | $191.02M derived: sum of 2 quarters · filed 2018-03-15 | |||
| 2015-12-31 | $176.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $203.29M 10-K · filed 2018-03-15 | |||
| 2015-09-30 | $26.35M 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |